Cargando…

Shunt resistance is associated with clinically important outcomes after the Norwood operation

BACKGROUND: In single-ventricle physiology, focus on pulmonary vascular resistance neglects the resistance in the conduit supplying the pulmonary inflow. METHODS: Conduit length and diameter, which can approximate conduit resistance, are available in the public dataset of Single Ventricle Reconstruc...

Descripción completa

Detalles Bibliográficos
Autores principales: Spigel, Zachary A., Qureshi, Athar M., Kalustian, Alyssa, Binsalamah, Ziyad M., Imamura, Michiaki, Caldarone, Christopher A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390403/
https://www.ncbi.nlm.nih.gov/pubmed/36003462
http://dx.doi.org/10.1016/j.xjon.2022.01.006
_version_ 1784770646842015744
author Spigel, Zachary A.
Qureshi, Athar M.
Kalustian, Alyssa
Binsalamah, Ziyad M.
Imamura, Michiaki
Caldarone, Christopher A.
author_facet Spigel, Zachary A.
Qureshi, Athar M.
Kalustian, Alyssa
Binsalamah, Ziyad M.
Imamura, Michiaki
Caldarone, Christopher A.
author_sort Spigel, Zachary A.
collection PubMed
description BACKGROUND: In single-ventricle physiology, focus on pulmonary vascular resistance neglects the resistance in the conduit supplying the pulmonary inflow. METHODS: Conduit length and diameter, which can approximate conduit resistance, are available in the public dataset of Single Ventricle Reconstruction (SVR) trial. Conduit resistance was then calculated for SVR trial participants and the relationship with clinically important variables (death or transplant at 1 year, pulmonary artery size at second-stage palliation, pulmonary-to-systemic blood flow ratio, and supplemental oxygen requirement) was explored. To validate this calculated resistance, calculated resistance was compared with catheterization measurements at a single institution (not included in the SVR trial). RESULTS: In the institutional dataset, calculated and measured resistances had an intraclass correlation of 0.78 for modified Blalock–Taussig shunts (MBTS). Within the SVR trial, transplant-free survivors had a lower MBTS resistance (median, 8.3 Woods Units [WU]. interquartile range [IQR], 6.5-11.1 WU) than patients who died or required transplantation (median, 13.0 WU; IQR, 9.4-16.6 WU, P = .0001). When we controlled for left pulmonary artery diameter after the Norwood procedure in the SVR trial, for each unit increase in MBTS resistance, the left pulmonary artery diameter at stage II decreased (–0.006 ± 0.002 cm, P = .005). When we controlled for pulmonary vascular resistance, greater MBTS resistance was associated with a decrease in log pulmonary-to-systemic blood flow ratio (–0.04 ± 0.015, P = .0048) in the SVR trial. Patients in the SVR trial requiring supplemental oxygen on admission for stage II palliation had greater MBTS resistance (median. 11.1 WU; IQR, 6.6-16.6 WU) than patients not requiring oxygen (median 8.3, WU; IQR, 6.5-11.1 WU, P = .015). CONCLUSIONS: Conduit resistance is associated with important clinical outcomes after Norwood; however, further studies are required to guide conduit resistance optimization.
format Online
Article
Text
id pubmed-9390403
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-93904032022-08-23 Shunt resistance is associated with clinically important outcomes after the Norwood operation Spigel, Zachary A. Qureshi, Athar M. Kalustian, Alyssa Binsalamah, Ziyad M. Imamura, Michiaki Caldarone, Christopher A. JTCVS Open Congenital: Norwood BACKGROUND: In single-ventricle physiology, focus on pulmonary vascular resistance neglects the resistance in the conduit supplying the pulmonary inflow. METHODS: Conduit length and diameter, which can approximate conduit resistance, are available in the public dataset of Single Ventricle Reconstruction (SVR) trial. Conduit resistance was then calculated for SVR trial participants and the relationship with clinically important variables (death or transplant at 1 year, pulmonary artery size at second-stage palliation, pulmonary-to-systemic blood flow ratio, and supplemental oxygen requirement) was explored. To validate this calculated resistance, calculated resistance was compared with catheterization measurements at a single institution (not included in the SVR trial). RESULTS: In the institutional dataset, calculated and measured resistances had an intraclass correlation of 0.78 for modified Blalock–Taussig shunts (MBTS). Within the SVR trial, transplant-free survivors had a lower MBTS resistance (median, 8.3 Woods Units [WU]. interquartile range [IQR], 6.5-11.1 WU) than patients who died or required transplantation (median, 13.0 WU; IQR, 9.4-16.6 WU, P = .0001). When we controlled for left pulmonary artery diameter after the Norwood procedure in the SVR trial, for each unit increase in MBTS resistance, the left pulmonary artery diameter at stage II decreased (–0.006 ± 0.002 cm, P = .005). When we controlled for pulmonary vascular resistance, greater MBTS resistance was associated with a decrease in log pulmonary-to-systemic blood flow ratio (–0.04 ± 0.015, P = .0048) in the SVR trial. Patients in the SVR trial requiring supplemental oxygen on admission for stage II palliation had greater MBTS resistance (median. 11.1 WU; IQR, 6.6-16.6 WU) than patients not requiring oxygen (median 8.3, WU; IQR, 6.5-11.1 WU, P = .015). CONCLUSIONS: Conduit resistance is associated with important clinical outcomes after Norwood; however, further studies are required to guide conduit resistance optimization. Elsevier 2022-01-22 /pmc/articles/PMC9390403/ /pubmed/36003462 http://dx.doi.org/10.1016/j.xjon.2022.01.006 Text en © 2022 Published by Elsevier Inc. on behalf of The American Association for Thoracic Surgery. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Congenital: Norwood
Spigel, Zachary A.
Qureshi, Athar M.
Kalustian, Alyssa
Binsalamah, Ziyad M.
Imamura, Michiaki
Caldarone, Christopher A.
Shunt resistance is associated with clinically important outcomes after the Norwood operation
title Shunt resistance is associated with clinically important outcomes after the Norwood operation
title_full Shunt resistance is associated with clinically important outcomes after the Norwood operation
title_fullStr Shunt resistance is associated with clinically important outcomes after the Norwood operation
title_full_unstemmed Shunt resistance is associated with clinically important outcomes after the Norwood operation
title_short Shunt resistance is associated with clinically important outcomes after the Norwood operation
title_sort shunt resistance is associated with clinically important outcomes after the norwood operation
topic Congenital: Norwood
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9390403/
https://www.ncbi.nlm.nih.gov/pubmed/36003462
http://dx.doi.org/10.1016/j.xjon.2022.01.006
work_keys_str_mv AT spigelzacharya shuntresistanceisassociatedwithclinicallyimportantoutcomesafterthenorwoodoperation
AT qureshiatharm shuntresistanceisassociatedwithclinicallyimportantoutcomesafterthenorwoodoperation
AT kalustianalyssa shuntresistanceisassociatedwithclinicallyimportantoutcomesafterthenorwoodoperation
AT binsalamahziyadm shuntresistanceisassociatedwithclinicallyimportantoutcomesafterthenorwoodoperation
AT imamuramichiaki shuntresistanceisassociatedwithclinicallyimportantoutcomesafterthenorwoodoperation
AT caldaronechristophera shuntresistanceisassociatedwithclinicallyimportantoutcomesafterthenorwoodoperation